Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
Biomarker
|
disease |
BEFREE |
KANSL1 haploinsufficiency causes Koolen-de Vries syndrome (KdVS), characterized by dysmorphic features and intellectual disability; amiable personality, congenital malformations and seizures also commonly occur.
|
29352316 |
2018 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
This case expands the mild end of the neurodevelopmental spectrum seen in children with de novo KANSL1 mutation and KdVS.
|
28211987 |
2017 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
This study was designed to describe the spectrum of epilepsy phenotypes in Koolen-de Vries syndrome (KdVS), a genetic syndrome involving dysmorphic features, intellectual disability, hypotonia, and congenital malformations, that occurs secondary to 17q21.31 microdeletions and heterozygous mutations in KANSL1.
|
28440867 |
2017 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
Biomarker
|
disease |
BEFREE |
Our results demonstrate the implication of KANSL1 in the manifestation of KdVS phenotypes and extend substantially our knowledge about biological processes affected by these mutations.
|
28704368 |
2017 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
GeneticVariation
|
disease |
CLINVAR |
Molecular diagnostic experience of whole-exome sequencing in adult patients.
|
26633545 |
2016 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
Biomarker
|
disease |
BEFREE |
Comparison of the phenotype of both the microdeletion and SNV patients does not show differences of clinical importance, stressing that haploinsufficiency of KANSL1 is sufficient to cause the full KdVS phenotype.
|
26306646 |
2016 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
CausalMutation
|
disease |
CLINVAR |
Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients.
|
26424144 |
2015 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome.
|
22544363 |
2012 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
CausalMutation
|
disease |
CLINVAR |
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype.
|
22544367 |
2012 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
CausalMutation
|
disease |
CLINVAR |
Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome.
|
22544363 |
2012 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
ChromosomalRearrangement
|
disease |
ORPHANET |
Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome.
|
19447831 |
2009 |
Chromosome 17q21.31 Deletion Syndrome
|
0.750 |
Biomarker
|
disease |
CTD_human |
|
|
|
Intellectual Disability
|
0.450 |
Biomarker
|
group |
BEFREE |
KANSL1 haploinsufficiency causes Koolen-de Vries syndrome (KdVS), characterized by dysmorphic features and intellectual disability; amiable personality, congenital malformations and seizures also commonly occur.
|
29352316 |
2018 |
Intellectual Disability
|
0.450 |
GeneticVariation
|
group |
BEFREE |
10-year-old female with intragenic KANSL1 mutation, no KANSL1-related intellectual disability, and preserved verbal intelligence.
|
28211987 |
2017 |
Intellectual Disability
|
0.450 |
Biomarker
|
group |
BEFREE |
KANSL1 gene expression studies and comparative clinical analysis of patients with 17q21.31 deletions and intragenic KANSL1 gene defects indicate that KANSL1 dysfunction is associated with the full spectrum of the 17q21.31 microdeletion syndrome, which includes characteristic facial features, hypotonia, intellectual disability, and structural defects of the brain, heart and genitourinary system, as well as, musculoskeletal and neuroectodermal anomalies.
|
26293599 |
2015 |
Intellectual Disability
|
0.450 |
GeneticVariation
|
group |
BEFREE |
The degree of intellectual disability (ID) appears to be milder than expected in a considerable number of subjects with either chromosome deletion or KANSL1 mutation.
|
26424144 |
2015 |
Intellectual Disability
|
0.450 |
Biomarker
|
group |
BEFREE |
We show that haploinsufficiency of KANSL1 is sufficient to cause the 17q21.31 microdeletion syndrome, a multisystem disorder characterized by intellectual disability, hypotonia and distinctive facial features.
|
22544363 |
2012 |
Intellectual Disability
|
0.450 |
Biomarker
|
group |
CTD_human |
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype.
|
22544367 |
2012 |
Intellectual Disability
|
0.450 |
Biomarker
|
group |
CTD_human |
We show that haploinsufficiency of KANSL1 is sufficient to cause the 17q21.31 microdeletion syndrome, a multisystem disorder characterized by intellectual disability, hypotonia and distinctive facial features.
|
22544363 |
2012 |
Intellectual Disability
|
0.450 |
Biomarker
|
group |
HPO |
|
|
|
Muscle hypotonia
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
We show that haploinsufficiency of KANSL1 is sufficient to cause the 17q21.31 microdeletion syndrome, a multisystem disorder characterized by intellectual disability, hypotonia and distinctive facial features.
|
22544363 |
2012 |
Muscle hypotonia
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype.
|
22544367 |
2012 |
Muscle hypotonia
|
0.400 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
ovarian neoplasm
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants.
|
31043753 |
2019 |
Malignant neoplasm of ovary
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants.
|
31043753 |
2019 |